HUT74167A - A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol - Google Patents

A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol Download PDF

Info

Publication number
HUT74167A
HUT74167A HU9600376A HU9600376A HUT74167A HU T74167 A HUT74167 A HU T74167A HU 9600376 A HU9600376 A HU 9600376A HU 9600376 A HU9600376 A HU 9600376A HU T74167 A HUT74167 A HU T74167A
Authority
HU
Hungary
Prior art keywords
starch
progesterone
pharmaceutical composition
composition according
estradiol
Prior art date
Application number
HU9600376A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9600376D0 (en
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of HU9600376D0 publication Critical patent/HU9600376D0/hu
Publication of HUT74167A publication Critical patent/HUT74167A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HU9600376A 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol HUT74167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon

Publications (2)

Publication Number Publication Date
HU9600376D0 HU9600376D0 (en) 1996-04-29
HUT74167A true HUT74167A (en) 1996-11-28

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600376A HUT74167A (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol

Country Status (17)

Country Link
EP (1) EP0789560A1 (da)
JP (1) JPH09501682A (da)
KR (1) KR960703570A (da)
CN (1) CN1132478A (da)
AU (1) AU7530594A (da)
BR (1) BR9407306A (da)
CA (1) CA2169840A1 (da)
CZ (1) CZ42596A3 (da)
DK (1) DK95093D0 (da)
FI (1) FI960749A7 (da)
HU (1) HUT74167A (da)
LT (1) LT4043B (da)
NO (1) NO960653L (da)
NZ (1) NZ271617A (da)
PL (1) PL313113A1 (da)
SK (1) SK19396A3 (da)
WO (1) WO1995005807A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
ES2319750T3 (es) * 1999-08-31 2009-05-12 Bayer Schering Pharma Aktiengesellschaft Composicion farmaceutica que comprende etinilestradiol y drospirenona para usar como anticonceptivo.
US6544553B1 (en) * 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768L (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
JP2005526083A (ja) * 2002-03-14 2005-09-02 ワトソン ファーマシューティカルズ， インコーポレイテッド プロゲステロンの経口薬物送達システム
WO2004096405A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
DK1874278T3 (da) 2005-04-28 2009-09-28 Wyeth Corp Sammensætninger indeholdende mikroniseret tanaproget
DE202007019049U1 (de) * 2007-11-05 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Verwendung eines Gestagens in Kombination mit einem Estrogen zur Prophylaxe der Laktoseintoleranz bei der oralen Kontrazeption
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
CA2856520C (en) * 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
WO2016210003A2 (en) 2015-06-22 2016-12-29 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
JPH09501682A (ja) 1997-02-18
CN1132478A (zh) 1996-10-02
CA2169840A1 (en) 1995-03-02
PL313113A1 (en) 1996-06-10
NZ271617A (en) 1996-11-26
BR9407306A (pt) 1996-10-08
EP0789560A1 (en) 1997-08-20
HU9600376D0 (en) 1996-04-29
KR960703570A (ko) 1996-08-31
AU7530594A (en) 1995-03-21
FI960749A0 (fi) 1996-02-19
LT4043B (en) 1996-09-25
WO1995005807A1 (en) 1995-03-02
LT96010A (da) 1996-06-25
FI960749L (fi) 1996-02-19
NO960653D0 (no) 1996-02-19
DK95093D0 (da) 1993-08-20
CZ42596A3 (en) 1996-06-12
FI960749A7 (fi) 1996-02-19
SK19396A3 (en) 1997-03-05
NO960653L (no) 1996-02-19

Similar Documents

Publication Publication Date Title
HUT74167A (en) A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol
KR102539030B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
CN101484143B (zh) 包含四氢叶酸的药物组合物
US20190269620A1 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AU2004275470B2 (en) Improved stability of progestogen formulations
CZ12896A3 (en) Sugar coating agent and moulded tablet
US20150290222A1 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP1461043A1 (en) Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation
CZ296387B6 (cs) Antikoncepcní prípravek
HU211931A9 (en) Two-stage contraception system and method using an estrogen and a progestin
CN107810001A (zh) 含雌四醇的口腔分散片剂
SK1292001A3 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
JP2002509524A (ja) エストロゲン化合物とプロゲステロン様化合物よりなるホルモン組成物
WO2024121800A1 (en) Extended-release pharmaceutical compositions of dydrogestrone
CN1167438A (zh) 新的激素药物及其用于矫正雌激素不足
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン
JP2003518013A (ja) 新規な避妊薬とその調製方法
US6670350B1 (en) Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same
Hale Phasic approach to oral contraceptives
KR102210982B1 (ko) 드로스피레논을 포함하는 약학적 조성물 및 피임용 키트
KR20010110807A (ko) 조합 치료에서의 항프로게스타겐의 용도
TW200936142A (en) Use of a gestagen in combination with an oestrogen and one or more pharmaceutically acceptable excipients/carriers, for lactose-free oral contraception
CZ2001364A3 (cs) Použití biogenních estrogensulfamátů k hormonální substituční terapii
CZ20001753A3 (cs) Balení pro antikoncepční účely
ZA200106689B (en) Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding.

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee